Booster Sessions of Dialectical Behavior Therapy for Youth at Risk for Bipolar Disorder
Tests extra dialectical behavior therapy booster sessions in youth with bipolar disorder risk.
Plain-language title generated from the registry record
Registry title: Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder
Key facts
- Where
- Toronto, CanadaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people with bipolar disorder, or with a parent or sibling who has it, who already finished a year of DBT in an earlier study. It tests booster sessions.
- Age
- 14 years to 26 years 11 months in the criteria (the registry lists 14 to 25 years).
- Sex
- All sexes can join.
- Disease stage
- Bipolar disorder confirmed by a standard interview, or a biological parent or sibling with bipolar disorder type I or II confirmed the same way.
- Earlier treatment
- Must have completed the DB1 or DB3 study. Must be followed by a psychiatrist. If bipolar I, must take at least 1 mood stabilizing medicine.
Main reasons for not taking part
- Life-threatening medical condition needing immediate treatment
- Current victim of sexual or physical abuse
- Substance use disorder, other than mild cannabis or alcohol use disorder
- Mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder that would interfere with DBT
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 14 and 25 years old?
Source: NCT05627492, who can take part
Where in Canada
- Centre for Addiction and Mental HealthToronto, CanadaContact: Vanessa Rajamani, MSWTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Centre for Addiction and Mental Health
- Trial code
- NCT05627492
- Record updated
- 1 October 2026
- Original description
The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder. Participants will have completed one full year of DBT in a previous study. This study is examining use of booster sessions. It is delivered in the form of individual sessions and skills sessions, based on the preference of the study participant. The study participant may also receive skills coaching via phone. There is no standard reference therapy/comparator against which the study intervention is being compared.Read full original descriptionShow less
Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder
The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder. Participants will have completed one full year of DBT in a previous study. This study is examining use of booster sessions. It is delivered in the form of individual sessions and skills sessions, based on the preference of the study participant. The study participant may also receive skills coaching via phone. There is no standard reference therapy/comparator against which the study intervention is being compared.
Inclusion: The participant must meet all of the inclusion criteria to eligible for this clinical trial:; Has completed participation in the DB1 study (049-2021) or the DB3 study (009-2021); English speaking; Age 14 years, 0 months to 26 years, 11 months; Meets diagnostic criteria for bipolar disorder by KSADS-PL(< 20 years of age) OR SCID-5-RV (≥ 20 years of age) OR have a biological parent/sibling with BD (type I or II) confirmed via KSADS-PL or SCID-5-RV; Followed by a psychiatrist who provides ongoing care; If BD-I, taking ≥1 mood stabilizing medication (i.e., antimanic anticonvulsant, antipsychotic, and/or lithium); Able and willing to give informed consent/assent to participate.
Exclusion: A life-threatening medical condition requiring immediate treatment; Current substance use disorder other than mild cannabis or alcohol use disorder; Evidence of mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder by the K-SADS-PL, parent report, medical history, or school records that would interfere with active participation in DBT; An individual who meets any of the following criteria will be excluded from participation in this clinical trial:; Current victim of sexual or physical abuse.